38.60000 EUR
4
9.39%
Last update Dec 17, 7:31 PM CET
Main market
Day range
38.60000
42.40000
Previous close
42.60000
Open
41.60000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
38.60
4
9.39%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 83.9M
Cost of revenue 26.2M
Gross profit 57.7M
Operating expense
Research & development 103.1M
Selling general and admin 65.4M
Other operating expenses
Operating income -110.8M
Non operating interest income
Income 12.4M
Expense 24.0M
Other income expense 20.7M
Pretax income -101.6M
Tax provision -203.7K
Net income -101.4M
Basic EPS -8.7
Diluted EPS -8.7
Basic average shares 11.7M
Diluted average shares 11.7M
EBITDA -95.0M
Net income from continuing op. -101.4M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 30 minutes

19:29
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).